Dermatomyasis superficialis (DS) is a rare disease that falls under the category of inflammatory myopathies. Inflammatory myopathies are a group of diseases that lead to inflammation of skeletal muscles and weakening of muscle strength. DS differs from other inflammatory myopathies in that it affects only the skin and muscles located directly under the skin.
DS is less common than other inflammatory myopathies and is most often diagnosed in people over 50 years of age. Women get DS twice as often as men.
Symptoms of DS include decreased muscle strength, muscle soreness, especially with movement, and skin rashes that can be red or purple and are often located on the face, neck, arms, and legs. Skin rashes may be sensitive to sunlight and worsen. Some patients may also experience fatigue, insomnia, and weight loss.
DS can be caused by a disorder of the immune system, but the exact causes of the disease are unknown. Various methods may be used to diagnose DS, including examination of skin rashes, blood tests for the presence of muscle antibodies, and a skin or muscle biopsy.
Treatment of DS includes the use of anti-inflammatory and immunosuppressive drugs such as corticosteroids, methotrexate and azathioprine. Physical therapy and stretching exercises can also help improve muscle strength and flexibility.
DS is a rare disease, but it can significantly impact a patient's quality of life. Early consultation with a doctor and diagnosis can help initiate treatment and improve the prognosis of the disease.